Zomedica (NYSEAMERICAN:ZOM) Trading Down 5.2%

Zomedica Corp. (NYSEAMERICAN:ZOM)’s stock price fell 5.2% during mid-day trading on Tuesday . The company traded as low as $0.13 and last traded at $0.13. 2,456,648 shares changed hands during trading, a decline of 47% from the average session volume of 4,653,531 shares. The stock had previously closed at $0.14.

Zomedica Stock Down 5.2 %

The stock has a market capitalization of $127.49 million, a PE ratio of -3.25 and a beta of 1.03.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Zomedica stock. Price T Rowe Associates Inc. MD lifted its position in Zomedica Corp. (NYSEAMERICAN:ZOM) by 41.1% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 948,300 shares of the company’s stock after buying an additional 276,100 shares during the period. Price T Rowe Associates Inc. MD owned approximately 0.10% of Zomedica worth $139,000 at the end of the most recent reporting period. 8.95% of the stock is owned by hedge funds and other institutional investors.

Zomedica Company Profile

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system.